Nia Therapeutics accepted into the Johnson & Johnson JPOD accelerator at the University of Pennsylvania

Nia Therapeutics was accepted into the initial cohort of the J&J JPOD accelerator program at the University of Pennsylvania’s Pennovation Center. The goal of JPOD is to identify and accelerate the development of early-stage healthcare solutions from the Philadelphia region’s life science ecosystem that address significant unmet patient and consumer needs.